Sign in

CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943134940
Phone
4154825300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Grant or award SVP & Chief Accounting Officer acquired 16,000 shares (grant or award)
  2. 4 Grant or award President & CEO acquired 106,650 shares (grant or award)
  3. 4 Grant or award SVP & Chief Commercial Officer acquired 28,550 shares (grant or award)
  4. 4 Grant or award SVP, COO & CFO acquired 40,000 shares (grant or award)
  5. 8-K Event Material agreement · Regulation FD disclosure
  6. 8-K Event Bylaws or fiscal year change
  7. 4 Open-market sale Director sold 1,560 shares at $17.82 ($27,799)
  8. 4 Open-market sale Chief R&D Officer sold 16,380 shares at $16.40 ($268,632)
  9. 4 Open-market sale Chief R&D Officer sold 29,618 shares at $16.93 ($501,433)
  10. 4 Open-market sale SVP & General Counsel sold 1,539 shares at $16.93 ($26,055)
  11. 4 Open-market sale SVP & Chief Accounting Officer sold 11,976 shares at $16.93 ($202,754)
  12. 4 Open-market sale President & CEO sold 11,975 shares at $16.93 ($202,737)
  13. 4 Open-market sale SVP, COO & CFO sold 8,276 shares at $16.93 ($140,113)
  14. 10-Q Report Quarterly Report
  15. 8-K Event Results of operations
  16. 8-K Event Executive or director change
  17. 4 Open-market sale Director sold 3,250 shares at $17.25 ($56,063)
  18. 4 Open-market sale Director sold 5,500 shares at $17.75 ($97,625)
  19. 4/A Grant or award Director acquired 9,100 shares (grant or award)
  20. 4/A Grant or award Director acquired 9,100 shares (grant or award)

Page 24 of 100 · 1,982 filings